Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activationDelivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation Chemyx Have any questions or comments about this article? Fill out the form below and we'll get back to you as soon as possible! Your Name (required) Your Email (required) Subject Your Message